HIV Prevention

Resource Center

Featured

Conference Coverage

TDF/FTC Considered Safe Among Pregnant Women Per Objective TFV-DP Levels

03/20/2023

CONFERENCE CONVERAGE

Urine Test Shows Predictive Values for PrEP Adherence

03/14/2023

pop quiz

Common Barriers to PrEP Uptake

03/14/2023

Interactive Features

pop quiz

Common Barriers to PrEP Uptake

03/14/2023

Pop Quiz

Testing for Pregnancy in Women Using PrEP

02/24/2023

The CDC guidelines on pre-exposure prophylaxis use include a recommendation on the frequency of testing for pregnancy among women who intend to become pregnant and are taking PrEP. Are you familiar with...

02/24/2023

Pop Quiz

Informing Patients About PrEP

12/21/2022

Test Your Knowledge

Test Your Knowledge

Managing a High-Risk, Young Patient

11/21/2022

In this Test Your Knowledge quiz, Diana Finkel, DO, poses a clinical scenario and asks you how you would manage this patient who is at high risk for HIV and is attending college for the first time.

11/21/2022

Poll

Increasing Access to PrEP

11/15/2022

A recent study investigated whether an increase in access to PrEP would increase the likelihood of adherence to the medication. Do you think this would work in your practice?

11/15/2022

Clinical Insights

Podcast

Podcast

Current Barriers to HIV PrEP in the United States

02/13/2023

Video

Hepatitis C Virus Among Patients Taking PrEP

12/15/2022

Expert Q&A

Disparities in Uptake and Use of PrEP

12/09/2022

In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...

12/09/2022

Expert Q&A

Expert Q&A

Improved Access to PrEP

12/07/2022

Podcast

Podcast

New Approaches to HIV Prevention, Management of Patients With HIV

10/27/2022

HIV Prevention Snapshot

Reviewed by Daniel Erias, MD and Jeffrey Kwong, DNP, MPH, AGPCNP-BC

Overview

Pre-exposure prophylaxis (PrEP) is a preventive medication administered intravenously or orally to reduce the risk of human immunodeficiency virus (HIV) infection that may occur following sex or injection drug use.

Specialty Impact

Any licensed health care provider is able to prescribe PrEP. Among the health care providers who are most likely to prescribe PrEP are:

At-Risk Populations

Individuals who are at-risk of HIV transmission include:

Individuals who have had anal or vaginal sex in the past 6 months and
- had a parter with HIV
- had sex without consistently using a condom
- have been diagnosed with a sexually transmitted disease in the past 6 months
Individuals who inject drugs, have an injection partner with HIV, or who shares needles, syringes, or other drug injection equipment
Individuals who have previously been prescribed PrEP, have reported continued risk behavior, or previously used multiple courses of PrEP

Diagnostic Snapshot

The HIV Risk Incidence Index for Men Who Have Sex With Men (HIRI-MSM) and Injection Drug Users Risk Index (IDU) are often used to stratify risk in patients.

Patient Data

Sources:

Research Summaries

CONFERENCE CONVERAGE

Urine Test Shows Predictive Values for PrEP Adherence

03/14/2023

Research Summary

Post-Exposure Prophylaxis for STI Prevention for Individuals With HIV, On PrEP

01/26/2023

Research Summary

Research Summary

Increased Prevalence of STIs Among Patients Undergoing PrEP Testing

01/11/2023

preventive medicine

preventive medicine

PrEP Is Underutilized in Emergency Department Settings

11/29/2022

medication use

Global Data Assessment of HIV PrEP Awareness, Willingness to Use

03/27/2022

Researchers conducted a systematic review and meta-analysis of data among men who have sex with men to investigate the awareness of pre-exposure prophylaxis (PrEP) and willingness to use PrEP.

03/27/2022

March 2023

Current Issue

March 2023

Volume 63

Issue 3